REQUEST A DEMO
Total
USD $0.00
Search more companies

Sturomedica D. Radzikowska sp. k. (Poland)

Main Activities: Pharmacies and Drug Stores
Secondary Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers | Cosmetics, Beauty Supplies, and Perfume Stores | Other Direct Selling Establishments | Outpatient Care Centers
Full name: Sturomedica D. Radzikowska sp. k. Profile Updated: May 08, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Sturomedica D. Radzikowska sp. k. is based in Poland. The head office is in Nadarzyn. The company operates in the Pharmacies and Drug Stores sector. Sturomedica D. Radzikowska sp. k. was incorporated on October 18, 2021. The company’s latest financial report indicates a net sales revenue increase of 90.46% in 2023. There was a total growth of 19.07% in Sturomedica D. Radzikowska sp. k.’s total assets over the same period. The net profit margin of Sturomedica D. Radzikowska sp. k. decreased by 24.98% in 2023.

Headquarters
Ul. Kasztanowa 17
Nadarzyn; Mazowieckie; Postal Code: 05-830

Contact Details: Purchase the Sturomedica D. Radzikowska sp. k. report to view the information.

Basic Information
Financial Auditors:
Purchase the Sturomedica D. Radzikowska sp. k. report to view the information.
Incorporation Date:
October 18, 2021
Key Executives
Purchase this report to view the information.
Associate Partner
Purchase this report to view the information.
Limited Partner
Company Performance
Financial values in the chart are available after Sturomedica D. Radzikowska sp. k. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
90.46%
Total operating revenue
90.16%
Operating profit (EBIT)
-5.37%
EBITDA
-0.29%
Net Profit (Loss) for the Period
-11.87%
Total assets
19.07%
Total equity
37.87%
Operating Profit Margin (ROS)
-24.22%
Net Profit Margin
-24.98%
Return on Equity (ROE)
-35.84%
Quick Ratio
1.14%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?